Ohio Retirement Fund Invests in Insmed Incorporated (INSM)

Insmed Incorporated (NASDAQ:INSM) is among the most promising biotech stocks to buy according to hedge funds. In the second quarter, Public Employees Retirement System of Ohio acquired a new stake in Insmed Incorporated (NASDAQ:INSM) through the purchase of 55,425 shares. According to a recent disclosure with the SEC, the fund’s investment in the company amounts to approximately $5,578,000.

During the presentation at the Morgan Stanley 23rd Annual Global Healthcare Conference, management revealed that Insmed Incorporated (NASDAQ:INSM) witnessed an exceptionally strong 18 months. With the market value growth of about $27 billion, the company maintains its focus on three key franchises, as they call it: ARIKAYCE, brensocatib, and TPIP.

While offering multibillion-dollar compounds, each of these candidates strengthens the company’s business mix. One area Insmed Incorporated (NASDAQ:INSM) is an expert at is identifying an unmet need and then delivering of its top-tier medicines. So, with a characteristic like this, the company is poised for long-term growth.

Insmed Incorporated (NASDAQ:INSM), headquartered in Bridgewater, New Jersey, specializes in therapies for patients with serious and rare diseases. Founded in 1988, the company is committed to transforming the lives of its patients.

While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.